Harnessing AI for Smarter Antigen Selection & More Effective TCE Design
- Using ML to integrate diverse datasets and map antigen prevalence across cancer and normal tissues
- Applying the 3T-TRACE platform to assess TCR and TCR-mimetic specificity and off-target cross-reactivity
- Engineering highly specific and safe T-cell engagers against shared targets for effective treatment of solid tumors